Gain Therapeutics CEO says 2025 ‘poised to be another pivotal year’
Gain Therapeutics (GANX) provided a letter to shareholders from the Company’s President and CEO, Gene Mack, which read in part,”With 2025 ...
Taiwan News22 小时
Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update
Gain’s lead program in Parkinson’s disease has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA, ...